Practice Transformation: Expanding the Role of Pharmacists and Pharmacies in HIV and HCV Care and Prevention
  • CME

This CME/CPE-certified interactive video module provides in-depth expert perspectives on systems that facilitate expanded pharmacist involvement in HIV and HCV management and key factors required for implementation of HIV and HCV screening, prevention, and other care services in community pharmacy settings.
John Faragon, PharmD, BCPS, AAHIVP
Program Director
Michelle T. Martin, PharmD, FCCP, BCPS, BCACP
Rupa Patel, MD, MPH, DTM&H
Physicians: maximum of 1.25 AMA PRA Category 1 Credits
Pharmacists: 1.25 contact hours (0.125 CEUs)
Released: May 22, 2019 Expiration: May 21, 2020
Multimedia Practice Transformation: Expanding the Role of Pharmacists and Pharmacies in HIV and HCV Care and Prevention
This program is divided into short segments. After reviewing all segments, click the Claim Credit button to complete the CME posttest and evaluation.
Introduction
See an overview of the activity and review the scope of unmet need that remains for HIV and HCV prevention and treatment in the United States.
Launch Introduction
Model 1: Pharmacist Colocated With Provider in Ambulatory Clinic
Gain insights on the features and benefits of a care system in which the clinical pharmacist provides extensive HCV management in an ambulatory care clinic, including a description of key tools that facilitate this model of care
Launch Model 1: Pharmacist Colocated With Provider in Ambulatory Clinic
Model 2: Pharmacist Colocated With Provider in Inpatient Setting
Review the important HIV management services that pharmacists can provide in an inpatient hospital setting to improve safety and virologic outcomes for patients and provide critical assistance to the heathcare team
Launch Model 2: Pharmacist Colocated With Provider in Inpatient Setting
Model 3: Pharmacists in Community Pharmacies
Learn about the essential systems needed for implementing PrEP services in a community pharmacy setting, and consider the feasibility of establishing these systems in your own pharmacy setting to expand PrEP, HIV, and/or HCV service provision
Launch Model 3: Pharmacists in Community Pharmacies
Closing Thoughts: It all Starts With Screening
Assess the central role of screening for all aspects of HIV and HCV prevention and management, and review examples of pilot programs evaluating screening in community pharmacy settings
Launch Closing Thoughts: It all Starts With Screening

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Establish systems that optimize the delivery of PrEP, HIV, and HCV services in the pharmacy setting
  • Implement strategies to increase pharmacist involvement in PrEP, HIV, and HCV care
  • Identify how pharmacy-based models of PrEP, HIV, and HCV service provision benefit patients and providers

Acknowledgements

Provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
Gilead Sciences, Inc.
ViiV Healthcare

Information on this Educational Activity

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME/CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Program Director

John Faragon, PharmD, BCPS, AAHIVP

Pharmacist, HIV and HCV Medicine
Albany Medical Center
Regional Pharmacy Director
Northeast/Caribbean AIDS Education and Training Center (AETC)
Albany, New York

John Faragon, PharmD, BCPS, AAHIVP, has disclosed that he has received fees for non-CME/CE services from AbbVie, Gilead Sciences, Janssen, Merck, and ViiV.

Faculty

Michelle T. Martin, PharmD, FCCP, BCPS, BCACP

Clinical Pharmacist
University of Illinois Hospital and Health Sciences System
Clinical Associate Professor
University of Illinois at Chicago College of Pharmacy
Chicago, Illinois

Michelle T. Martin, PharmD, FCCP, BCPS, BCACP, has disclosed that she has received consulting fees and funds for research support from Gilead Sciences and that she has ownership interest in AbbVie, Gilead Sciences, and Merck.
Rupa Patel, MD, MPH, DTM&H

Assistant Professor
Division of Infectious Diseases
Director, Pre-Exposure Prophylaxis (PrEP) Program
Washington University
St Louis, Missiouri

Rupa Patel, MD, MPH, DTM&H, has disclosed that she has received consulting fees from Gilead Sciences.

Staff

Jennifer Blanchette, PhD

Senior Scientific Director

Jennifer M. Blanchette, PhD, has no real or apparent conflicts of interest to report.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.
Anna Poppa

Editorial Contributor

Anna Poppa has no real or apparent conflicts of interest to report.

The PIM planners and managers have nothing to disclose.

Charles E. Willis, Director of Continuing Education; Amanda Sewell, MBA, Manager of Continuing Education and Melissa Velasquez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for US pharmacists and other healthcare providers who care for patients with or at risk of HIV and HCV infection.

Goal

The goal of this activity is to improve pharmacists’ competence in contributing to the prevention and management of HIV and HCV infection.

Physician Continuing Medical Education

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

This program is assigned ACPE Universal Activity 0797-9999-19-058-H02-P. This program is designated for up to 1.25 contact hours (0.125 CEUs) of continuing pharmacy education credit.

Type of Activity Application

For Pharmacists: Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from May 22, 2019, through May 21, 2020:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 50% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?